athebio.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
# Squarespace Robots Txt User-agent: AdsBot-Google Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* Disallow:/*&tag=* Disallow:/*?month=* Disallow:/*&month=* Disallow:/*?view=* Disallow:/*&view=* Disallow:/*?format=json Disallow:/*&format=json Disallow:/*?format=page-context Disallow:/*&format=page-context Disallow:/*?format=main-content Disallow:/*&format=main-content Disallow:/*?format=json-pretty Disallow:/*&format=json-pretty Disallow:/*?format=ical Disallow:/*&format=ical Disallow:/*?reversePaginate=* Disallow:/*&reversePaginate=* User-agent: AdsBot-Google-Mobile Disallow: /config Disallow: /search Disallow: /account$ Disallow: /account/ Disallow: /commerce/digital-download/ Disallow: /api/ Allow: /api/ui-extensions/ Disallow: /static/ Disallow:/*?author=* Disallow:/*&author=* Disallow:/*?tag=* | ||
Meta Tags
| Title | ATHEBIO - We empower drug |
| Description | Enabling next-generation targeted Athebio develops advanced binding molecules based on repeat proteins to help drug developers fill their pipelines with innovative drug |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 198.185.159.145 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
athebio.com Valuation
|
US$618,958
Last updated: 2023-05-16 18:54:09
athebio.com has Semrush global rank of 17,100,206. athebio.com has an estimated worth of US$ 618,958, based on its estimated Ads revenue. athebio.com receives approximately 71,419 unique visitors each day. Its web server is located in United States, with IP address 198.185.159.145. According to SiteAdvisor, athebio.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$618,958 |
| Daily Ads Revenue | US$572 |
| Monthly Ads Revenue | US$17,141 |
| Yearly Ads Revenue | US$205,685 |
| Daily Unique Visitors | 4,762 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| athebio.com. | A | 300 | IP: 198.185.159.145 |
| athebio.com. | A | 300 | IP: 198.49.23.144 |
| athebio.com. | A | 300 | IP: 198.49.23.145 |
| athebio.com. | A | 300 | IP: 198.185.159.144 |
| athebio.com. | NS | 3600 | NS Record: ns.hostpoint.ch. |
| athebio.com. | NS | 3600 | NS Record: ns2.hostpoint.ch. |
| athebio.com. | NS | 3600 | NS Record: ns3.hostpoint.ch. |
| athebio.com. | MX | 3600 | MX Record: 10 athebio-com.mail.protection.outlook.com. |
| athebio.com. | TXT | 300 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
HtmlToTextCheckTime:2023-05-16 18:54:09
| ATHEBIO Home About us Technology Partnering Career News Contact Follow us Home About us Technology Partnering Career News Contact Follow us ATHEBIO Scroll Enabling next-generation targeted therapeutics. We enable drug developers to create superior targeted therapeutics of advanced efficacy and safety and thereby increased probability of clinical success. Based on our proprietary Athebody® DARPin platform we provide our partners with leading-edge “plug & play” binding building blocks, that can easily be plugged into a broad range of existing drug modalities. Let’s talk News Athebio Enters Development and License Agreement with Acuitas Therapeutics Athebio AG appoints Dr. Hans-Peter Gerber as Scientific Advisor more news We are here to explore and unlock the therapeutic potential of repeat proteins and make it available to the world. Our Technology Athebio has brought the DARPin technology to the next level through the development of its proprietary Athebody® DARPin Platform. Athebody® |
HTTP Headers
HTTP/1.1 301 Moved Permanently Age: 257444 Date: Fri, 04 Feb 2022 11:31:12 GMT Location: https://www.athebio.com/ Server: Squarespace Set-Cookie: crumb=BXD7nBT2kb4rMmNjNDk1MDA4NzZlOWFmZjMxOGRhOGVlN2YwZWFi;Path=/ X-Contextid: svgbFSHx/O4n8iwNE HTTP/2 200 accept-ranges: bytes age: 10182 cache-control: max-age=172800, s-maxage=172800 content-type: text/html;charset=utf-8 date: Mon, 07 Feb 2022 08:12:15 GMT expires: Thu, 01 Jan 1970 00:00:00 GMT server: Squarespace set-cookie: crumb=BQ5SWGPmlGAEYTJlMzMxNDhlMGY2NTJmZTgzYjcxNTY0OGMyMTlh;Path=/ strict-transport-security: max-age=0 vary: Accept-Encoding x-content-type-options: nosniff x-contextid: cMEwNRxC/AqHnrIiT |
athebio.com Whois Information
Domain Name: ATHEBIO.COM Registry Domain ID: 2401690041_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2021-06-14T07:11:59Z Creation Date: 2019-06-13T12:15:22Z Registry Expiry Date: 2022-06-13T12:15:22Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: NS.HOSTPOINT.CH Name Server: NS2.HOSTPOINT.CH Name Server: NS3.HOSTPOINT.CH DNSSEC: unsigned >>> Last update of whois database: 2022-02-07T07:51:50Z <<< |